Compare ANIP & LZB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANIP | LZB |
|---|---|---|
| Founded | 2001 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Home Furnishings |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.6B |
| IPO Year | 1999 | 1994 |
| Metric | ANIP | LZB |
|---|---|---|
| Price | $71.99 | $31.94 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $110.00 | $39.00 |
| AVG Volume (30 Days) | 397.3K | ★ 701.1K |
| Earning Date | 05-08-2026 | 06-16-2026 |
| Dividend Yield | N/A | ★ 2.75% |
| EPS Growth | ★ 419.23 | 5.11 |
| EPS | ★ 2.32 | N/A |
| Revenue | $206,547,000.00 | ★ $2,349,433,000.00 |
| Revenue This Year | $21.01 | $1.89 |
| Revenue Next Year | $17.59 | $2.09 |
| P/E Ratio | $31.49 | ★ N/A |
| Revenue Growth | ★ 2.47 | N/A |
| 52 Week Low | $70.15 | $29.03 |
| 52 Week High | $99.50 | $44.90 |
| Indicator | ANIP | LZB |
|---|---|---|
| Relative Strength Index (RSI) | 38.23 | 30.11 |
| Support Level | $70.15 | $31.76 |
| Resistance Level | $83.43 | $39.96 |
| Average True Range (ATR) | 1.97 | 1.15 |
| MACD | -0.20 | -0.40 |
| Stochastic Oscillator | 9.50 | 7.50 |
ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.
La-Z-Boy Inc is a world'wide producer of reclining chairs and one of the manufacturers/distributors of residential furniture in the United States. It manufacture, market, import, export, distribute and retail upholstery furniture products. In addition, it import, distribute and retail accessories and casegoods (wood) furniture products. Its reportable operating segments include the Retail segment and the Wholesale segment. Its Retail segment mainly sells upholstered furniture. Wholesale segment manufactures and imports upholstered and casegoods (wood) furniture and sells directly. The company generates majority of revenue from Wholesale segment which manufactures and imports upholstered furniture, such as recliners and motion furniture, sofas, loveseats, chairs, sectionals, modulars, etc.